Skip to main content
Article thumbnail
Location of Repository

OPEN ACCESS Research Article

By Stefan Pscherer and Eva Susanne Dietrich

Abstract

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany Kostenvergleich von Insulin glargin mit Insulin detemir im Rahmen einer Basis-Bolus-Behandlung (ICT) mit mahlzeitenbezogenem Insulin aspart bei Typ-2-Diabetes in Deutschland Objective: To compare the treatment costs of insulin glargine (IG; Lantus ® ) to detemir (ID; Levemir ®), both combined with bolus insulin aspart (NovoRapid ® ) in type 2 diabetes (T2D) in Germany

Topics: insulin glargine, insulin detemir, basal insulin, type 2 diabetes, cost analysis
Year: 2013
OAI identifier: oai:CiteSeerX.psu:10.1.1.352.1140
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • ftp://ftp.ncbi.nlm.nih.gov/pub... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.